To Seek or Not to Seek Parallel European Medicine Agency and Health Technology Assessment Scientific Advice?
Abstract
The authors examine the pros and cons of seeking parallel regulatory-HTA guidance during clinical development and discusses the importance of scientific advice in ensuring regulatory approval and HTA acceptance.
Authors
Thomas Bramley Eldon Spackman Angsgar Hebborn LoAn K. Ho Benjamin Parcher Trent McLaughlin